A method for treating myocardial or skeletal muscle anoxia which occurs in coronary or post-infarct disorders or during prolonged physical activity and muscle fatigue. This method comprises the administration of a combination composition comprising (a) an alkanoyl L-carnitine selected from the group consisting of isovaleryl L-carnitine, propionyl L-carnitine or the pharmacologically acceptable salts thereof or mixtures thereof; and (b) ribose or a phosphate derivative thereof.

Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose

Pietro; Pola

The administration of ribose raises the hypoxic threshold of mammals experiencing a hypoxic condition. The presence of an effective amount of ribose in the tissue of a mammal increases the tolerance to hypoxia and decreases the symptoms of hypoxia in mammals experiencing chronic hypoxia due to cardiovascular disease or peripheral vascular disease. Such mammals are additionally benefited by administration of ribose and a vasodilator or an isotropic agent. Mammals experiencing transient hypoxia from high altitude, anesthesia or exercise are also benefited.

ribose/hypoxia

Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose

Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose

Method for raising the hypoxic threshold

Baz done ki pi konplè remèd fèy medsin te apiye nan syans